A NOVEL LC-MS/MS METHOD FOR SIMULTANEOUS QUANTIFICATION OF RESVERATROL AND FERULIC ACID IN COMMERCIALLY AVAILABLE FACIAL OIL

By:

Contributor(s):

Publication details: JSSCP OOTY JSS AHER, Mysore 2022Description: 200

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Status	Barcode
M Pharm Thesis	JSS College of Pharmacy, Ooty	JSS College of Pharmacy, Ooty	Pharmaceutical Analysis	Available	EPR2689

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	CONCURRENT ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF AZELNIDIPINE, OLMESARTAN MEDOXOMIL AND TELMISARTAN BY RP-HPLC METHOD	CONCURRENT ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ATORVASTATIN, GLIMEPIRIDE, METFORMIN AND RAMIPRIL BY RP-HPLC	STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF UDENAFIL AND CHARACTERIZATION OF DEGRADATION PRODUCTS BY RP-HPLC AND LC-MS/MS	A NOVEL LC-MS/MS METHOD FOR SIMULTANEOUS QUANTIFICATION OF RESVERATROL AND FERULIC ACID IN COMMERCIALLY AVAILABLE FACIAL OIL	615.5 ADY Method Development And Validation Of Esomeprazole Delayed Release Capsules By Assay	615.5 BAL An Stability Indicating Assay Method For Valsartan (Api) Isolation And Identification Of Nitrosamine Impurity By Rp-Hplc, Lc-Ms/Ms	615.5 BEL Related Impurity Determination In Active Pharmaceutical Ingredient Of Montelukast Sodium By Hplc	Next

There are no comments on this title.

to post a comment.